These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31437587)

  • 1. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
    Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
    Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
    Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
    Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
    Zhou S; Rulach R; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Lau YC; Paterson C
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):665-673. PubMed ID: 32561027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy
    Zhou S; Chan C; Lau YC; Rulach R; Dyab H; Hendry F; Wilson C; Schipani S; Lamb C; Grose D; James A; Maxfield C; Dempsey MF; Paterson C
    Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):e699-e707. PubMed ID: 37798198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
    Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
    Zhou S; Chan C; Rulach R; Dyab H; Hendry F; Maxfield C; Dempsey MF; James A; Grose D; Lamb C; Schipani S; Wilson C; Cheng Lau Y; Paterson C
    Oral Oncol; 2022 May; 128():105870. PubMed ID: 35447564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
    Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
    Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
    Bird T; Barrington S; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1239-47. PubMed ID: 26707387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttreatment surveillance PET/CT for HPV-associated oropharyngeal cancer.
    Corpman DW; Masroor F; Carpenter DM; Nayak S; Gurushanthaiah D; Wang KH
    Head Neck; 2019 Feb; 41(2):456-462. PubMed ID: 30549345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
    Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
    Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive accuracy of first post-treatment PET/CT in HPV-related oropharyngeal squamous cell carcinoma.
    Koshkareva Y; Branstetter BF; Gaughan JP; Ferris RL
    Laryngoscope; 2014 Aug; 124(8):1843-7. PubMed ID: 24474646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
    Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
    Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
    Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
    Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.